PMDA drug package insert
麗皇珀薬泉
PMDA OTC drug · 新大和漢方（株） · package insert Apr 9, 2021
Key facts
| Brand names | 麗皇珀薬泉 |
|---|---|
| Companies | 製造販売元／ワキ製薬（株）,販売会社／新大和漢方（株） |
| Product type | OTC drug |
| OTC risk class | 第３類医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | ビタミンC主薬製剤 |
| Package insert date | Apr 9, 2021 |
| PMDA document key | 890020_J2101000022 |
| PMDA company code | 890020 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: